Medical innovations are rapidly expanding therapy options for many diseases. Keep reading to find more information on new therapies, surgical techniques, effective medication and patient care.
As TIL therapy remains difficult to access across Germany and Austria, Sheba offers more than 15 years of experience, in-house cell manufacturing, and one of the world's leading cellular therapy programs for advanced melanoma.
Severe back pain and fractures may hint at pregnancy- and lactation-associated osteoporosis (PLO). A new publication aims to help healthcare professionals identify and treat women with PLO.
Strong compression is important for people with venous leg ulcers, to improve blood flow and support healing. Now, a study explores the pros and cons of different bandages, wraps, and stockings.
Transgender and gender diverse individuals undergoing gender-affirming mastectomy (‘top surgery’) often lack information on how the procedure will affect breast cancer risk, a new study finds.
As access to TIL therapy remains limited across Europe, Sheba Medical Center combines 15+ years of experience, in-house manufacturing, and pioneering research to advance melanoma and CAR-T therapies.
The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to its Board of Directors. Beth Erickson, MD, FASTRO, has been elected President of the medical society.
Results from a recently published clinical trial suggest that combining focused ultrasound with chemotherapy may improve tumor response and survival outcomes in patients with pancreatic cancer.
A new position statement urges orthopaedic surgeons and bone health specialists to work together to assess and treat osteoporosis before and after joint replacement and spinal fusion surgery.
Ultra-fast delivery, fewer side-effects: Results from the FAST-02 trial show that proton Flash therapy can be safely delivered to cancer patients with metastases in proximity to vital organs.
Using dual mobility total hip replacements (DM-THR) instead of the standard THR approach greatly reduces the likelihood of dislocation post-surgery, a new study finds.
Researchers have found a way to avoid second surgery for unborn babies with a severe diaphragmatic defect. To complete the procedure, the mother now only has to take a short stroll.
A Dublin hospital completed Europe's first robotic-assisted shoulder replacement using Stryker's Mako platform, expanding the technology beyond hip and knee surgery.
A pilot study shows that immunotherapy may enable stimulation of egg maturation in women with premature menopause. Three out of ten women gave birth to healthy babies following the treatment.
Radiopharmaceutical therapy has already transformed care for neuroendocrine tumors and prostate cancer, but other tumor types still lack targeted treatment options. A new approach could change this.
A new survey highlights major gaps in cardio-oncology training, despite its increasing clinical importance for prevention and early management of cardiovascular complications in patients with cancer.
For patients with knee osteoarthritis, for whom injections no longer provide sufficient relief, but joint replacement is also not an option, a minimally invasive treatment might offer an alternative.
To treat gastric leaks after weight loss surgery, doctors usually rely on a device not suited for the task. This may result in further complications. A redesigned stent could help fix this issue.
A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options.
For decades, patients have been strictly advised to use single-use catheters to prevent urinary tract infections (UTIs). However, a new study suggests that reusable options are equally safe.
A new clinical trial has identified new opportunities to improve recovery for intensive care survivors through remote rehabilitation delivered in patients’ homes.
Due to advances in radiation therapy, some breast cancer patients may be able to omit surgery following ablative radiation, according to new results of a Phase 2 trial.
Once breast cancer begins to metastasise, it generally becomes harder to treat and survival rates are lower. Now, researchers present a new, targeted treatment approach using SBRT radiotherapy.
United Imaging debuts its CE-marked uRT-linac 506c at ESTRO 2026 – a CT-linac system with native AI architecture for adaptive radiotherapy workflows.
A CRISPR-based tool called Cas12a2 can selectively eliminate cancer and virus-infected cells based on their RNA signature – with high precision and no off-target effects.
Total hip replacement performed with robotic techniques has a lower reoperation rate than the conventional procedure, according to a six-year study.
